Lyxor FTSE MIB (DR) UCITS ETF is a equity ETF from Amundi tracking the FTSE MIB index through physical replication. Domiciled in Francia and launched in 2003, the fund manages about 699 M € and charges a TER of 0.35% — 35 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Lyxor FTSE MIB (DR) UCITS ETF competes with 3 other products on the same index (FTSE MIB): it ranks 1st by fund size and 3rd by ongoing cost, with a TER of 0.35% against a group median of 0.34%. It has been listed since 2003, 23 years of track record — the oldest in its comparison group.
On a €10,000 investment the TER costs 35 € a year. The cheapest of the group is Xtrackers FTSE MIB UCITS ETF 1D at 0.30%, or 30 € on the same amount: a difference of 5 € every year, roughly 50 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 71.8% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Francia, which determines the tax treatment of income received by the fund and the supervisory authority.
| UniCredit S.p.A. | 16.0% |
| Intesa Sanpaolo SpA | 12.4% |
| Enel SpA | 10.3% |
| Prysmian SpA | 5.7% |
| STMicroelectronics N.V. | 5.6% |
| Assicurazioni Generali S.p.A. | 5.5% |
| Eni S.p.A. | 5.2% |
| Ferrari NV | 5.2% |
| Banco Bpm SpA | 3.0% |
| Banca Monte dei Paschi di Siena SpA | 2.9% |
| Borsa Italiana | ETFMIB | EUR |
| London Stock Exchange | MIBX | GBX |
| Euronext Paris | MIB | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.